Provectus Biopharma (PVCT) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	5.18M
Prepaid expenses and other current assets
Total Current Assets	5.42M
Equipment and furnishings, less accumulated depreciation of $413,219 and $409,442	75.22K
Patents, net of amortization of $5,782,817 and $5,447,257, respectively	2.41M
Other assets	27K
Total Assets	10.69M
Accounts payable - trade	1.49M
Accrued compensation and payroll taxes
Accrued consulting expense	192K
Other accrued expenses	355.23K
Total Current Liabilities	5.38M
Warrant liability	3.34M
Total Liabilities
Preferred stock; par value $.001 per share; 25,000,000 shares authorized; 4,218,332 and 5,389,998 shares issued and outstanding, respectively, liquidation preference (in aggregate $3,227,973 and $4,122,245, respectively)	18
Common stock; par value $.001 per share; 150,000,000 authorized; 108,659,601 and 91,297,883 shares issued and outstanding, respectively	243.9K
Paid-in capital	205.29M
Deficit accumulated during the development stage	-200.22M
Total Stockholders' Equity	5.31M
Total Liabilities And Stockholders' Equity	10.69M

Entities mentioned with PVCT

View All Entities